An Open-Label Drug Interaction Study in Healthy Subjects to Evaluate the Effects of Multiple Doses of JNJ55308942 on the Cytochrome P450 CYP3A4, CYP2D6 and CYP2C19 Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2018
Price : $35 *
At a glance
- Drugs JNJ-55308942 (Primary) ; Dextromethorphan; Ethinylestradiol/levonorgestrel; Midazolam; Omeprazole
- Indications Epilepsy; Inflammation; Inflammatory bowel diseases; Mood disorders
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 27 Sep 2018 Status changed from recruiting to completed.
- 29 Jun 2018 Status changed from not yet recruiting to recruiting.
- 11 Jun 2018 New trial record